Lung cancer is one of the most deadly diseases all around the world. Various companies are during clinical trials to offer better and effective treatment options for those suffering from lung cancer….
Category: Lung Cancer News
New Study Finds A Way To Stop Key Lung Cancer Spread Protein
Lung cancer is among the most common types of cancers prevailing all over the world. A new study by Tulane University has found a molecular pathway to stop lung cancer spread. The…
Durvalumab for Treatment of Lung Cancer
Durvalumab is a type of immunotherapy and is known by its brand name, Imfinzi. Its role in treatment of small cell lung cancer is increasing. Durvalumab injection is injected into a vein…
Indoor Wood Burning Raises Lung Cancer Risk among Women, Says US Study
According to a new research, wood burning stoves and fireplaces could pose a higher health cancer risk. The study involved 50,000 women and they found that a significant correlation between frequent use…
Machine Learning Model to Identify Lung Cancer Risk Prediction
Lung cancer is the common cause of cancer deaths worldwide and the leading reason is the absence of early detection. In most cases, lung cancer is often detected at a later stage…
J & J Lung Cancer Therapy Succeeds in Study with AstraZeneca’s Drug, Tagrisso
A head-to-head matchup between Johnson & Johnson combination and AstraZeneca’s drug, Tagrisso as a first-line treatment for non-small cell lung cancer has yielded J & J as the winner. In the MARIPOSA…
Trial Shows Novel Vaccine’s Potential for Lung Cancer Treatment
A new vaccine has shown to improve survival rate among people suffering from lung cancer. A French biotechnology company said that Ose Immunotherapeutics’ Tedopi vaccine was effective in decreasing death risk among lung…
Israeli Researchers Identify Relapse-free Treatment for Lung Cancer
The research team of Weizmann Institute have identified biomarker that helps to prevent relapse of certain types of lung cancer. This new Israeli study could open ways to more efficient treatment for…
Quratusugene Ozeplasmid for Small Cell Lung Cancer Receives Orphan Drug Designation by FDA
Genprex, Inc. is a clinical-stage gene therapy company and has announced the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to the drug, Reqorsa Immunogene Therapy (quratusugene…
Study Finds Outdoor Air Pollution May Increase Non-Lung Cancer Risk
Air pollution has been considered as a risk factor for lung cancer and a link to breast cancer risk is also emerging. But, few studies have looked into the effects on air…
Blood Testing Technology called GEMINI for Early Detection of Lung Cancer
Researchers have come up with a new blood testing technology called GEMINI (Genome-wide Mutational Incidence for Non-Invasive Detection of Cancer). This technology utilizes genome-wide sequencing of single molecules of DNA along with…
Sublober Resection for Surgical Treatment of Non-Small Cell Lung Cancer
Lung cancer is among common forms of cancers and is responsible for most deaths from cancers all over the world. One standard care for lung cancer is labectomy for surgical treatment of…